Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04879225
Other study ID # IRB00065077
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 21, 2021
Est. completion date December 29, 2022

Study information

Verified date April 2022
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge of tobacco regulation is weighing the risks and benefits of potential policies across different populations (i.e., users and non-users). Tension arises between policies intended to prevent adolescent and young adult (AYA) tobacco initiation and those intended to reduce harm among current tobacco users. The availability of menthol e-liquids may be important for encouraging menthol cigarette smokers to switch to e- cigarettes, but mint e-liquids, which are appealing to AYA, may be unnecessary to facilitate switching. Including mint e-liquids in flavor bans but allowing menthol e-liquids to remain on the market as potential substitution products for menthol smokers may be an optimal policy approach. The study team is proposing a lab study and field assessment to determine how including menthol and mint e-liquids in e-liquid flavor bans or sales restrictions affects tobacco product purchasing and use among menthol cigarette smokers. At lab sessions, participants will complete the Experimental Tobacco Marketplace (ETM) task, a behavioral economics task in which they receive account balances to an online store and can buy menthol cigarettes at escalating costs or buy e-liquids, non-menthol cigarettes, or nicotine replacement gum at fixed costs. They will complete the task under four marketplace conditions: (1) only tobacco e-liquids available, (2) menthol and tobacco e-liquids available, (3) menthol, mint, and tobacco e-liquids available, and (4) tobacco, menthol, mint, fruit, dessert. During a field assessment, product choice is validated by assessing use of products purchased during the ETM task. This proposal will inform policy-makers about the impact banning menthol and mint e-liquids will have on facilitating menthol cigarette smokers switching to e-cigarettes.


Description:

The study team proposes to conduct a within-subjects, multi-session virtual lab study and validation field assessment to determine how the availability of menthol and mint e-liquids affects product purchasing among menthol cigarette smokers. Adult daily menthol cigarette smokers will be recruited for this study. After initial eligibility is assessed, participants will complete six virtual sessions and one field assessment to evaluate their tobacco use. Participants will be recruited from Winston-Salem, North Carolina (NC) and the surrounding area using advertisements on public transit, community flyers, and social media. Curbside visits to drop off biosamples and pickup study products will be conducted outside the Wake Forest Tobacco Control Center of Excellence located in Biotech Place in the Innovation Quarter. The study team anticipates recruiting up to 100 participants to achieve 80 completers. Equal numbers of black and white participants will be enrolled.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date December 29, 2022
Est. primary completion date December 29, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: 1. 21+ years of age 2. Self-report smoking at least 5 cigarettes per day for the past year 3. Self-report smoking menthol cigarette brands > 80% of the time 4. Breathe carbon monoxide (CO) level > 8 ppm Willingness to use other tobacco products during the study 5. Speak, comprehend, and read English sufficiently to complete study procedures 6. Have home access to a computer or tablet with a web camera and internet access Exclusion Criteria: 1. Currently seeking treatment to quit smoking 2. Self-reported serious medical or psychiatric condition(s) including cardiovascular and chronic respiratory diseases 3. Body temperature > 100.4 F 4. Cold, flu or Novel Coronavirus (COVID-19) symptoms including fever, cough, and runny nose in the past 30 days 5. Currently pregnant, breastfeeding or intending to become pregnant for the duration of the study or unwilling to agree to use adequate protection to avoid pregnancy 6. CO reading > 80 ppm 7. Enrollment stratum (Non-Hispanic, white or Black/African American)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tobacco e-liquids
Marketplace includes tobacco flavored e-liquids
Menthol and Tobacco e-liquids
Marketplace includes menthol and tobacco flavored e-liquids
Mint, Menthol and Tobacco e-liquids
Marketplace includes mint, menthol and tobacco flavored e-liquids
All e-liquid flavors
Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids

Locations

Country Name City State
United States Wake Forest Health Sciences Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Total amount of non-menthol cigarettes Total amount purchased when menthol cigarettes are not available according to race Day 3, Day 4, Day 5, Day 6
Other Total Amount of Tobacco e-liquid Purchased Total amount of tobacco e-liquid purchased when menthol cigarettes are not available according to race. Day 3, Day 4, Day 5, Day 6
Other Total Amount of Menthol e-liquid Purchased Total amount of menthol e-liquid purchased when menthol cigarettes are not available according to race. Day 3, Day 4, Day 5, Day 6
Other Total Amount of Mint e-liquid Purchased Total amount of mint e-liquid purchased when menthol cigarettes are not available according to race. Day 3, Day 4, Day 5, Day 6
Other Total amount of dessert/fruit e-liquid purchased. Total amount of dessert/fruit e-liquid purchased when menthol cigarettes are not available according to race. Day 3, Day 4, Day 5, Day 6
Other Themes emerging from the qualitative interviews Qualitative interviews will be conducted and then analyzed in an effort to learn common themes or trends among the participants specific to various tobacco and nicotine products. Day 14
Other Mean Perceived Health Risk Scale Score This is a measure of the perceived addictive potential and other health risks associated with cigarettes, e-cigarettes and nicotine gum. Scale 1-10 (1=very low risk of disease and 10=very high risk of disease). Each item/question has a score of 1-10. There are 14 different items in this questionnaire and each item will be evaluated independently. Baseline, Day 14
Other Mean Product Evaluation Scale Score This scale measures the participant's experience while using cigarettes, nicotine gum, or vaping devices. Each of the three products will include 13 items with a total score range of 13-91 for each of the three products. A higher score denotes more enjoyment from the product. Baseline, Day 14
Other Mean Minnesota Nicotine Withdrawal Scale Score This is a 15-item self-reported scale to evaluate the effects of smoking cessation and withdrawal symptoms. This scale is important because it allows the researchers to understand the experience of the participant throughout the study while using various tobacco products. The study team will use 7/15 items from this scale each ranging in score from 1-5. Total score range for the questionnaire would be 7-35 with higher score denoting more severe symptoms. Baseline, Day 3, Day 4, Day 5, Day 6, Day 14
Other Mean Questionnaire on Smoking Urges Score This scale measures the person's urge to smoke throughout the study while potentially using various tobacco and nicotine products. This questionnaire consists of 10 items each ranging from 1-7. Total score range for the entire questionnaire is 10-70. A higher score denotes greater urge. Baseline, Day 3, Day 4, Day 5, Day 6, Day 14
Other Mean Tobacco Product Interest Scores A visual analog scale assessing interest in use of various tobacco and nicotine products. Each item has a score from 0-100. This scale ranges from no interest (0) to very interested (100). The total questionnaire has 9 items that will be evaluated independently. The study team is looking at the following:
Preferred cigarette brand
Any other cigarette brand
A cigarette brand with 95% less nicotine
I Quit Ordinary Smoking (IQOS) Heat-Not-Burn Device
Juice Universal Serial Bus Lighting (JUUL) Vaping Device
Zyn Nicotine Pouches
NicoDerm Nicotine Patch
Nicorette Nicotine Lozenge
Nicorette Nicotine Gum
Baseline, Day 14
Other Tobacco Policy Questionnaire Score A visual analog scale assessing interest in use of various tobacco and nicotine products. This questionnaire will assess support for various tobacco control policies, including banning menthol flavoring in cigarettes and e-cigarettes. Each of the 14 items has a score of 1-3. 1 means the subject is supportive of the policy, 2 means subject is opposed. 3 indicates that the subject does not know. Each of the 14 items will be evaluated independently from one another. Baseline, Day 14
Primary Total amount of combusted tobacco purchased Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available. Day 3
Primary Total amount of combusted tobacco purchased Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available. Day 4
Primary Total amount of combusted tobacco purchased Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available. Day 5
Primary Total amount of combusted tobacco purchased Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available. Day 6
Secondary Total amount of tobacco e-liquid purchased Total amount of tobacco e-liquid purchased when menthol cigarettes are not available. Day 3, Day 4, Day 5, Day 6
Secondary Total amount of menthol e-liquid purchased Total amount of menthol e-liquid purchased when menthol cigarettes are not available. Day 3, Day 4, Day 5, Day 6
Secondary Total amount of mint e-liquid purchased Total amount of mint e-liquid purchased when menthol cigarettes are not available Day 3, Day 4, Day 5, Day 6
Secondary Total amount of dessert and fruit e-liquid purchased Total amount of dessert and fruit e-liquid purchased with menthol cigarettes are not available Day 3, Day 4, Day 5, Day 6
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02385227 - Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes N/A
Completed NCT02218281 - Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation N/A
Completed NCT01199380 - Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms Phase 2
Completed NCT00756704 - The Effectiveness of Smoking Cessation Guidelines in the Emergency Department N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT00802919 - Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors Phase 4
Completed NCT01692353 - Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers N/A
Completed NCT00682474 - School Nurse-Delivered Smoking Cessation Intervention Phase 2/Phase 3
Completed NCT05520775 - Semaglutide for Alcohol Use Disorder Phase 2
Terminated NCT03840694 - Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior N/A
Not yet recruiting NCT06032793 - Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness. N/A
Terminated NCT03326128 - High Dose Bupropion for Smoking Cessation - Pilot Study Phase 2
Recruiting NCT03218670 - Your Health in On Click N/A
Completed NCT02538042 - Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue) N/A
Completed NCT02792426 - Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users Phase 1